Login / Signup

Nirmatrelvir/Ritonavir Compared With Placebo/Ritonavir for Long COVID: A Comment.

Hineptch DaungsupawongViroj Wiwanitkit
Published in: The American journal of medicine (2024)
Keyphrases
  • coronavirus disease
  • sars cov
  • antiretroviral therapy
  • double blind
  • randomized controlled trial
  • open label